Recently, timed-release bromocriptine (Cycloset), a sympatholytic dopamine D 2 receptor agonist, has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of type 2 diabetes.
6d
News-Medical.Net on MSNScientists confirm neurobiochemical link between dopamine and cognitive flexibilityFor the first time, scientists have confirmed a neurobiochemical link between dopamine and cognitive flexibility, according ...
Receptors that, when activated, can cause nausea or vomiting or both include dopamine type 2, serotonin type 3, histamine type 1, and muscarinic cholinergic type 1 receptors. Patients at moderate ...
Scientists have confirmed a neurobiochemical link between dopamine and cognitive flexibility. PET imaging shows that the brain increases dopamine production when completing cognitively demanding tasks ...
For the first time, scientists have confirmed a neurobiochemical link between dopamine and cognitive ... participants were scanned with the D 2/3 receptor ligand 18 F-fallypride in a two-part ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results